Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma.
Sravanthi LavuTerry M TherneauWilliam S HarmsenKristin C ColeNicha WongjarupongMohamed HassanHamdi A AliSamuel O AntwiNasra H GiamaKatsuyuki MiyabeLewis Rowland RobertsPublished in: Hepatology (Baltimore, Md.) (2020)
This case-control study suggests that statins decrease the risk of ECC and may improve survival in patients with dCCA. Additional validation studies are warranted.